OPTIC NERVE PROTECTING AGENT CONTAINING ALPHA 1-RECEPTOR BLOCKING DRUG AS ACTIVE INGREDIENT

Title:

OPTIC NERVE PROTECTING AGENT CONTAINING ALPHA 1-RECEPTOR BLOCKING DRUG AS ACTIVE INGREDIENT

Document Type and Number:

Japanese Patent JP2003081874

Kind Code:

A

Abstract:

To find a new pharmacological effect of an alpha 1-receptor blocking drug.

Alpha 1-receptor blocking drugs was studied for their new pharmacological effects, and it was found that they have an optical nerve protecting effect. Accordingly, an alpha 1-receptor blocking drug is useful as an optical nerve protecting agent for treating normal intraocular pressure glaucoma, and retinal diseases represented by retinal vascular occlusion, diabetic retinopathy, ischemic optic neuropathy, macular degeneration, retinal pigmentary degeneration and Leber's disease.

More Like This:

JP4499106	Triazole derivative as an inhibitor of 11-beta-steroid dehydrogenase-1
WO/2016/090495	TARGETED α-L-IDURONIDASE CONJUGATES AND USES THEREOF
WO1999000128	ANTITHROMBOTIC AGENTS

Inventors:

MIYAWAKI NOBUAKI
HARA HIDEAKI
GOTO WAKANA

Application Number:

JP2002191570A

Publication Date:

March 19, 2003

Filing Date:

July 01, 2002

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SANTEN PHARMACEUTICAL CO LTD
EISAI CO LTD

International Classes:

C07D249/16; A61K31/495; A61K31/496; A61K31/517; A61K31/551; A61K45/00; A61P3/10; A61P9/10; A61P27/02; A61P27/06; A61P43/00; C07D239/95; C07D295/08; C07D405/12; (IPC1-7): A61K45/00; A61K31/495; A61K31/496; A61K31/517; A61K31/551; A61P3/10; A61P9/10; A61P27/02; A61P27/06; A61P43/00

Attorney, Agent or Firm:

Eisuke Kishimoto (3 others)

Previous Patent: PROPHYLACTIC OR THERAPEUTIC AGENT FOR ORGAN FUNCTIONAL DISORDER AND ORGAN INSUFFICIENCY

Next Patent: LOCALLY APPLICABLE COMPOSITION FOR COSMETIC AND/OR DERMATOLOGICAL PREPARATION AND/OR MEDICINE CONTAI...